 | • レポートコード：C-GIR20G1796 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「組換えタンパク質ワクチンの世界市場2019年」は、グローバルにおける組換えタンパク質ワクチン市場を展望するレポートです。組換えタンパク質ワクチンのグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・組換えタンパク質ワクチンの市場概観 ・組換えタンパク質ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・組換えタンパク質ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・組換えタンパク質ワクチンの世界市場規模 ・組換えタンパク質ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・組換えタンパク質ワクチンのアメリカ市場規模推移 ・組換えタンパク質ワクチンのカナダ市場規模推移 ・組換えタンパク質ワクチンのメキシコ市場規模推移 ・組換えタンパク質ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・組換えタンパク質ワクチンのドイツ市場規模推移 ・組換えタンパク質ワクチンのイギリス市場規模推移 ・組換えタンパク質ワクチンのロシア市場規模推移 ・組換えタンパク質ワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・組換えタンパク質ワクチンの日本市場規模推移 ・組換えタンパク質ワクチンの中国市場規模推移 ・組換えタンパク質ワクチンの韓国市場規模推移 ・組換えタンパク質ワクチンのインド市場規模推移 ・組換えタンパク質ワクチンの東南アジア市場規模推移 ・組換えタンパク質ワクチンの南米市場分析（ブラジル、アルゼンチン等） ・組換えタンパク質ワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・組換えタンパク質ワクチンの種類別分析/販売量、売上、市場シェア（細菌細胞培養、哺乳類細胞培養） ・組換えタンパク質ワクチンの用途別分析/市場規模（人間、動物） ・組換えタンパク質ワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・組換えタンパク質ワクチンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Recombinant Protein Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Recombinant Protein Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Indian Immunologicals
Plumbline Life Sciences
Zoties
GSK
Merck
Sanofi
Medicago
Boehringer-Ingelheim
Elanco
Novavax
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bacterial Cells Culture
Mammalian Cells Culture
Market Segment by Applications, can be divided into
Human
Animal
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Protein Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Protein Vaccine, with price, sales, revenue and global market share of Recombinant Protein Vaccine in 2017 and 2018.
Chapter 3, the Recombinant Protein Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Protein Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Recombinant Protein Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Recombinant Protein Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Protein Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Bacterial Cells Culture
1.2.2 Mammalian Cells Culture
1.3 Market Analysis by Applications
1.3.1 Human
1.3.2 Animal
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Indian Immunologicals
2.1.1 Business Overview
2.1.2 Recombinant Protein Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Plumbline Life Sciences
2.2.1 Business Overview
2.2.2 Recombinant Protein Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Zoties
2.3.1 Business Overview
2.3.2 Recombinant Protein Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zoties Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 GSK
2.4.1 Business Overview
2.4.2 Recombinant Protein Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GSK Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Recombinant Protein Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Recombinant Protein Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Medicago
2.7.1 Business Overview
2.7.2 Recombinant Protein Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medicago Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Boehringer-Ingelheim
2.8.1 Business Overview
2.8.2 Recombinant Protein Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Elanco
2.9.1 Business Overview
2.9.2 Recombinant Protein Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Elanco Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novavax
2.10.1 Business Overview
2.10.2 Recombinant Protein Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novavax Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Recombinant Protein Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Recombinant Protein Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Recombinant Protein Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Protein Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Recombinant Protein Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Recombinant Protein Vaccine Market Analysis by Regions
4.1 Global Recombinant Protein Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Protein Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Recombinant Protein Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
5 North America Recombinant Protein Vaccine by Country
5.1 North America Recombinant Protein Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Protein Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Recombinant Protein Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
6 Europe Recombinant Protein Vaccine by Country
6.1 Europe Recombinant Protein Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Protein Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Recombinant Protein Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
6.4 France Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Recombinant Protein Vaccine by Country
7.1 Asia-Pacific Recombinant Protein Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Recombinant Protein Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Recombinant Protein Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
7.5 India Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
8 South America Recombinant Protein Vaccine by Country
8.1 South America Recombinant Protein Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Protein Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Recombinant Protein Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Recombinant Protein Vaccine by Countries
9.1 Middle East and Africa Recombinant Protein Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Recombinant Protein Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Recombinant Protein Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
10 Global Recombinant Protein Vaccine Market Segment by Type
10.1 Global Recombinant Protein Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Recombinant Protein Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Recombinant Protein Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Bacterial Cells Culture Sales Growth and Price
10.2.1 Global Bacterial Cells Culture Sales Growth (2014-2019)
10.2.2 Global Bacterial Cells Culture Price (2014-2019)
10.3 Mammalian Cells Culture Sales Growth and Price
10.3.1 Global Mammalian Cells Culture Sales Growth (2014-2019)
10.3.2 Global Mammalian Cells Culture Price (2014-2019)
11 Global Recombinant Protein Vaccine Market Segment by Application
11.1 Global Recombinant Protein Vaccine Sales Market Share by Application (2014-2019)
11.2 Human Sales Growth (2014-2019)
11.3 Animal Sales Growth (2014-2019)
12 Recombinant Protein Vaccine Market Forecast (2019-2024)
12.1 Global Recombinant Protein Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Recombinant Protein Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Recombinant Protein Vaccine Market Forecast (2019-2024)
12.2.2 Europe Recombinant Protein Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Recombinant Protein Vaccine Market Forecast (2019-2024)
12.2.4 South America Recombinant Protein Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Recombinant Protein Vaccine Market Forecast (2019-2024)
12.3 Recombinant Protein Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Recombinant Protein Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Recombinant Protein Vaccine Market Share Forecast by Type (2019-2024)
12.4 Recombinant Protein Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Recombinant Protein Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Recombinant Protein Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Recombinant Protein Vaccine Picture
Table Product Specifications of Recombinant Protein Vaccine
Figure Global Sales Market Share of Recombinant Protein Vaccine by Types in 2018
Table Recombinant Protein Vaccine Types for Major Manufacturers
Figure Bacterial Cells Culture Picture
Figure Mammalian Cells Culture Picture
Figure Recombinant Protein Vaccine Sales Market Share by Applications in 2018
Figure Human Picture
Figure Animal Picture
Figure United States Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure France Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure China Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure India Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Recombinant Protein Vaccine Revenue (Value) and Growth Rate (2014-2024)
Table Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table Indian Immunologicals Recombinant Protein Vaccine Type and Applications
Table Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors
Table Plumbline Life Sciences Recombinant Protein Vaccine Type and Applications
Table Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zoties Basic Information, Manufacturing Base and Competitors
Table Zoties Recombinant Protein Vaccine Type and Applications
Table Zoties Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Recombinant Protein Vaccine Type and Applications
Table GSK Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Recombinant Protein Vaccine Type and Applications
Table Merck Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Recombinant Protein Vaccine Type and Applications
Table Sanofi Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Medicago Basic Information, Manufacturing Base and Competitors
Table Medicago Recombinant Protein Vaccine Type and Applications
Table Medicago Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer-Ingelheim Recombinant Protein Vaccine Type and Applications
Table Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Elanco Basic Information, Manufacturing Base and Competitors
Table Elanco Recombinant Protein Vaccine Type and Applications
Table Elanco Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Recombinant Protein Vaccine Type and Applications
Table Novavax Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Recombinant Protein Vaccine Sales by Manufacturer (2017-2018)
Figure Global Recombinant Protein Vaccine Sales Market Share by Manufacturer in 2017
Figure Global Recombinant Protein Vaccine Sales Market Share by Manufacturer in 2018
Table Global Recombinant Protein Vaccine Revenue by Manufacturer (2017-2018)
Figure Global Recombinant Protein Vaccine Revenue Market Share by Manufacturer in 2017
Figure Global Recombinant Protein Vaccine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Recombinant Protein Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Recombinant Protein Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Global Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Global Recombinant Protein Vaccine Revenue and Growth Rate (2014-2019)
Table Global Recombinant Protein Vaccine Sales by Regions (2014-2019)
Table Global Recombinant Protein Vaccine Sales Market Share by Regions (2014-2019)
Table Global Recombinant Protein Vaccine Revenue by Regions (2014-2019)
Figure Global Recombinant Protein Vaccine Revenue Market Share by Regions (2014-2019)
Figure Global Recombinant Protein Vaccine Revenue Market Share by Regions in 2018
Figure North America Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure South America Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure North America Recombinant Protein Vaccine Revenue and Growth Rate (2014-2019)
Table North America Recombinant Protein Vaccine Sales by Countries (2014-2019)
Table North America Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table North America Recombinant Protein Vaccine Revenue by Countries (2014-2019)
Table North America Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure United States Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Canada Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Mexico Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Protein Vaccine Revenue and Growth Rate (2014-2019)
Table Europe Recombinant Protein Vaccine Sales by Countries (2014-2019)
Table Europe Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Table Europe Recombinant Protein Vaccine Revenue by Countries (2014-2019)
Figure Europe Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure Europe Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure Germany Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure UK Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure France Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Russia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Italy Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Protein Vaccine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Recombinant Protein Vaccine Sales by Countries (2014-2019)
Table Asia-Pacific Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Recombinant Protein Vaccine Sales Market Share by Countries 2018
Table Asia-Pacific Recombinant Protein Vaccine Revenue by Countries (2014-2019)
Figure Asia-Pacific Recombinant Protein Vaccine Revenue Market Share by Countries 2018
Figure China Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Japan Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Korea Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure India Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure South America Recombinant Protein Vaccine Revenue and Growth Rate (2014-2019)
Table South America Recombinant Protein Vaccine Sales by Countries (2014-2019)
Table South America Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure South America Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table South America Recombinant Protein Vaccine Revenue by Countries (2014-2019)
Table South America Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure South America Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Argentina Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Colombia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Recombinant Protein Vaccine Sales by Countries (2014-2019)
Table Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Recombinant Protein Vaccine Revenue by Countries (2014-2019)
Table Middle East and Africa Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure UAE Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Egypt Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure Nigeria Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Figure South Africa Recombinant Protein Vaccine Sales and Growth Rate (2014-2019)
Table Global Recombinant Protein Vaccine Sales by Type (2014-2019)
Table Global Recombinant Protein Vaccine Sales Share by Type (2014-2019)
Table Global Recombinant Protein Vaccine Revenue by Type (2014-2019)
Table Global Recombinant Protein Vaccine Revenue Share by Type (2014-2019)
Figure Global Bacterial Cells Culture Sales Growth (2014-2019)
Figure Global Bacterial Cells Culture Price (2014-2019)
Figure Global Mammalian Cells Culture Sales Growth (2014-2019)
Figure Global Mammalian Cells Culture Price (2014-2019)
Table Global Recombinant Protein Vaccine Sales by Application (2014-2019)
Table Global Recombinant Protein Vaccine Sales Share by Application (2014-2019)
Figure Global Human Sales Growth (2014-2019)
Figure Global Animal Sales Growth (2014-2019)
Figure Global Recombinant Protein Vaccine Sales, Revenue and Growth Rate (2019-2024)
Table Global Recombinant Protein Vaccine Sales Forecast by Regions (2019-2024)
Table Global Recombinant Protein Vaccine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Recombinant Protein Vaccine Market Forecast (2019-2024)
Figure Europe Sales Recombinant Protein Vaccine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Recombinant Protein Vaccine Market Forecast (2019-2024)
Figure South America Sales Recombinant Protein Vaccine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Recombinant Protein Vaccine Market Forecast (2019-2024)
Table Global Recombinant Protein Vaccine Sales Forecast by Type (2019-2024)
Table Global Recombinant Protein Vaccine Market Share Forecast by Type (2019-2024)
Table Global Recombinant Protein Vaccine Sales Forecast by Application (2019-2024)
Table Global Recombinant Protein Vaccine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の組換え細胞培養サプリメント市場予測（～2024年） Recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing. Scope of the Report: The global Recombinant Cell Culture Supplements market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 202…- ヒト胚性幹細胞（HESC）市場：世界及び中国市場分析・予測（～2024年） Human Embryonic Stem Cells (HESC) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Embryonic Stem Cells (HESC) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hu…
- 世界の球状タンパク質市場予測（～2024年）：メーカー別、地域別、種類・用途別 Globular proteins or spheroproteins are spherical proteins and are one of the common protein types. Globular proteins are somewhat water-soluble, unlike the fibrous or membrane proteins. Scope of the Report: The worldwide market for Globular Protein is expected to grow at a CAGR of roughly xx% over …
- 血液培養検査の世界市場 2019年版：種類別（細菌感染症、真菌感染症、マイコバクテリア感染症）、用途別（病院研究所、参照研究所、その他） Scope of the Report: The global Blood Culture Tests market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also …
- 遺伝子ワクチンの世界市場 2019年版：種類別（組換えタンパク質ワクチン、遺伝子ベースワクチン）、用途別（人間、動物） Scope of the Report: The worldwide market for Genetic Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Genetic Vaccine in glob…